$AbCellera Biologics(ABCL)$ $AbCellera Biologics(ABCL)$ ABCL is quietly becoming the Palantir of antibodies.
Palantir built the data engine. ABCL is building the AI engine for drug discovery.
They're not just chasing one drug at a time. They're creating the operating system that helps pharma companies find treatments faster.
Their tech basically maps the immune system, sifting through millions of cells to hunt down the right antibody.
Both companies are good at turning messy, massive datasets into something useful when everyone else just sees noise.
ABCL is trying to change how medicine gets made.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
